Between 2013 and 2023, the number of stem cell transplants performed on patients in Finland showed considerable fluctuation. Starting at 268 units in 2013, the figures experienced highs in 2015 and 2017, reaching 329 and 401 units respectively. However, there was a notable decline in 2019, with procedures dropping to 208 units before recovering to 341 units by 2020. In 2023, the volume stood at 354 units, indicating an upward trend with a year-on-year variation of 3.51%. The compound annual growth rate (CAGR) over the past 5 years displayed mild growth at 0.75%.
Looking forward, the forecasted data from 2024 to 2028 suggests a steady increase in procedures, with figures growing from 365 units in 2024 to 410 units by 2028. The projected 5-year CAGR is 2.35%, representing an overall growth of 12.33% over this period.
Future trends to watch for include advancements in stem cell transplantation techniques, increased accessibility to treatments, and policy changes that could impact the healthcare system in Finland. Keeping an eye on global medical innovations and demographic shifts will also provide insights into the ongoing demand for these procedures.
